Martin, J.; Neubauer, V.; Rittersberger, R.; Treitler, S.; Kopp, P.; Günday, C.; Shrimo, I.; Dabbars, A.; Rosenau, F.; Türeli, A.E.;
et al. Development and Characterization of a Primary Ciliated Porcine Airway Model for the Evaluation of In Vitro Mucociliary Clearance and Mucosal Drug Delivery. Pharmaceutics 2025, 17, 462.
https://doi.org/10.3390/pharmaceutics17040462
AMA Style
Martin J, Neubauer V, Rittersberger R, Treitler S, Kopp P, Günday C, Shrimo I, Dabbars A, Rosenau F, Türeli AE,
et al. Development and Characterization of a Primary Ciliated Porcine Airway Model for the Evaluation of In Vitro Mucociliary Clearance and Mucosal Drug Delivery. Pharmaceutics. 2025; 17(4):462.
https://doi.org/10.3390/pharmaceutics17040462
Chicago/Turabian Style
Martin, Janik, Veronika Neubauer, Rebecca Rittersberger, Simon Treitler, Patrick Kopp, Cemre Günday, Iman Shrimo, Annabelle Dabbars, Frank Rosenau, Akif Emre Türeli,
and et al. 2025. "Development and Characterization of a Primary Ciliated Porcine Airway Model for the Evaluation of In Vitro Mucociliary Clearance and Mucosal Drug Delivery" Pharmaceutics 17, no. 4: 462.
https://doi.org/10.3390/pharmaceutics17040462
APA Style
Martin, J., Neubauer, V., Rittersberger, R., Treitler, S., Kopp, P., Günday, C., Shrimo, I., Dabbars, A., Rosenau, F., Türeli, A. E., Günday-Türeli, N., Haedicke-Peters, O., & Schindowski, K.
(2025). Development and Characterization of a Primary Ciliated Porcine Airway Model for the Evaluation of In Vitro Mucociliary Clearance and Mucosal Drug Delivery. Pharmaceutics, 17(4), 462.
https://doi.org/10.3390/pharmaceutics17040462
